UCLA researchers find that they can electronically recruit patients for biomedical research at rates up to 40 times higher than the traditional method of patient portal messages by embedding study recruitment into the pre-appointment preCheck-in page.
While patient portal messages are increasingly used to recruit patients for research studies, this method typically results in study enrollment rates of 1–8%. In addition, this method of study recruitment has historically led to under-representation of racial and ethnic minorities in biomedical research.
The researchers pioneered a new method of study recruitment called preCheck-in recruitment. This technique embedded all study recruitment material into the workflow that patients normally use to electronically check in before doctor visits. The researchers created a new functionality that allowed patients to review and electronically sign documents such as research authorization forms. They tested this new methodology in a two-week period in November, 2021 at a single UCLA primary care clinic.
Of 843 patients seen in the clinic during that time, 386 completed preCheck-in. Of those, 308 signed the research authorization form for a 37% study enrollment rate. The enrolled sample was socio-demographically representative of the health system at-large, suggesting preCheck-in recruitment may help improve representation in biomedical research.
The researchers sent post-appointment surveys to 93 of these patients, and 45 completed it for a 48% completion rate. The research is published in theThe findings are limited by inclusion of only patients with an active portal who had upcoming appointments with UCLA
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
UC researchers study parasite that causes Chagas diseaseAlmost everything about insects called kissing bugs is revolting, from the insidious way they bite people's faces at night to drink their blood while they sleep to the way they spread disease through their poop.
Lire la suite »
Keck School of Medicine researchers receive $12 million grant to study early liver transplantationAlcohol-associated liver disease accounts for 50% of liver-related deaths, and its rates are rising worldwide.
Lire la suite »
Researchers find vaccine may reduce severity of long-haul COVID symptomsGetting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.
Lire la suite »
Stowers researchers reveal why certain anti-cancer drugs can cause unexpected side effectsWith around 90% of drugs failing to make it to market, the potential for improving efficiency within the drug development industry is clear. Drugs designed to combat cancers suffer similar rates of failure for many reasons.
Lire la suite »
Oxford researchers find DNA in ancient clay brickExperts from the University of Oxford found evidence of cabbage from 2,900 years ago.
Lire la suite »
Researchers on the cusp of a new vaccine modality breakthroughProfessor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable particulate vaccine.
Lire la suite »